Abstracts

ANTI-PD-1 THERAPY INDUCED RAPID INNATE INTERFERON RESPONSES DRIVE HIV RESERVOIR DECAY

Background: Antiretroviral therapy (ART) is not curative and HIV patients continue to present with co-morbidities including cancer. Persistence of HIV in latently-infected CD4 T cells remains a major impediment to eradication. These cells express high levels of inhibitory receptor PD-1, which is associated with immune dysfunction in both HIV infection and cancer. Inhibitors that target…

AUTOLOGOUS NEUTRALIZING ANTIBODY RESPONSES IN bNAb-TREATED RHESUS MACAQUES

Background: Broadly neutralizing antibodies (bnAbs) are important tools for HIV-1 therapy and cure strategies, yet the role of autologous neutralizing antibodies (anAbs) during bnAb therapy is unclear. We studied the kinetics of anAb responses during VRC07523.LS therapy at analytical treatment interruption (ATI) in a robust SHIV-infected Rhesus Macaque (RM) model of HIV-1. Methods: 18 RMs…

SHIFTS IN SYSTEMIC INFLAMMATION AFTER FECAL MICROBIOTA TRANSPLANT IN PEOPLE WITH HIV

Background: Whether interventions on the microbiota can help reduce chronic inflammation during treated HIV infection remains unclear. In a fecal microbiota transplant (FMT) trial in PWH, we found that Lachnospiraceae and Ruminococcaceae families–with known anti-inflammatory properties– were the taxa more robustly engrafted across time points. Here, we aimed to better characterize the FMT effects on…

DEPLETION OF SIV-SPECIFIC CD8+ T CELLS DOES NOT ALTER VIRAL LOAD DURING SIV INFECTION

Background: The emergence of SIV-specific CD8+ T cells coincides with declining viremia in monkeys acutely infected with SIV. Antiviral CD8+ T cells may also contribute to immune control in chronically infected animals treated with antiretrovirals (ARVs). We explored these relationships using toxin-conjugated MHC class I tetramers to deplete Gag CM9-specific CD8+ T cells in Mamu-A01+…